Study of the Influence of the Expression of the Calcium-sensitive Receptor (CaSR) by Monocytes in the Synovial Liquid on Structural Alterations in Patients Diagnosed With Rheumatoid Arthritis in the Previous Two Years
Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Sep 5, 2016
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients consulting in the Department of Rheumatology at Amiens University Hospital
- • Age ≥ 18
- • RA meeting the 2010 ACR/EULAR criteria
- • Less than 2 years of RA progression
- • Effusion in at least 1 joint
- Exclusion Criteria:
- • Inability to give informed consent
- • Ongoing pregnancy
- • Previous treatment with an anti-osteoporosis medication
- • Intra-articular corticoid or hyaluronic acid injection in the previous 6 months
- • Coagulation disorders preventing arthrocentesis
- • Incarceration or legal guardianship
About Centre Hospitalier Universitaire, Amiens
The Centre Hospitalier Universitaire (CHU) Amiens is a leading academic medical center in France dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, CHU Amiens integrates patient care, education, and research to enhance treatment outcomes and improve patient quality of life. The institution is committed to ethical standards and regulatory compliance in its clinical research endeavors, aiming to contribute significantly to the medical community and the development of new therapeutic approaches. By fostering partnerships with various stakeholders, CHU Amiens strives to translate scientific discoveries into practical applications that benefit patients and healthcare systems alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Amiens, , France
Patients applied
Trial Officials
Vincent GOEB, MD, PhD
Principal Investigator
CHU Amiens
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials